7 peptides under active FDA review PCAC MEETING IN 15 DAYS
FindLegitPeptides status board · v2.4.0
GHK-Cu (injectable)
Copper Peptide GHK-Cu, injectable routes
Removed from Cat 2

Status is in flux. FDA review activity is ongoing, check before you commit.

PCAC review · 2027-02Disputed

Talk to a licensed clinician before acting on this.

Injectable form removed from Category 2 (Apr 2026), second PCAC review expected by Feb 2027

Recovery
Sources: Frier Levitt · FDA Law Blog

Same category

Related peptides

BPC-157Under PCAC reviewKPVUnder PCAC reviewTB-500Under PCAC reviewCathelicidin LL-37Removed from Cat 2

Before you spend a dollar: confirm the pharmacy is real, and know what a fair price looks like.

Verify a pharmacy See fair pricing